← Open Payments lookup

CHARLIE CRUCE: Open Payments

NPI 1962044800 · DERMOTT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 30 payments from 11 companies in 2025. Trend: 2023 $637 · 2024 $574 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
ABBVIE INC.14$155
Lundbeck LLC4$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
GlaxoSmithKline, LLC.2$33
AstraZeneca Pharmaceuticals LP2$27
PFIZER INC.1$19
Vanda Pharmaceuticals Inc.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$17
Axsome Therapeutics, Inc.1$16
Novo Nordisk Inc1$15

Products named: VRAYLAR, REXULTI, CAPLYTA, TRELEGY ELLIPTA, UBRELVY, ELIQUIS, HETLIOZ, JARDIANCE.

Industry payments across AR — which companies pay providers there.